67 /100
HIGH RISK
Score updated Apr 13, 2026

VVOS

Vivos Therapeutics, Inc. — Stock Dilution Tracker

Track VVOS dilution risk with DilutionWatch's stock tracker. DilutionScore™ measures dilution risk across 5 factors — lower scores indicate higher risk of share dilution.

🔔 Track VVOS — Get alerts when the score changes →
📊 Score Breakdown
📋 Offering Ability
60
💰 Cash Runway
85
📊 Float Risk
45
⚠️ Warrant Exposure
15
🔄Convertible Debt
🌦️ Dilution Forecast
🌥️
Advisory
Moderate dilution signals present
35%
🔄 Reverse Split 45%
• 50-day avg $1.39 approaching $1 threshold
• Only 4 months cash — financial pressure
💰 Capital Raise 35%
• Low cash runway: 4 months remaining
📉 Score Deterioration 10%
• Score in HIGH risk zone (67/100)
🔔 Track VVOS — Get forecast alerts →
💹 Market Data
Market Cap$14.30M
Shares Outstanding11.82M
Float6.77M
Cash$3.09M
Debt$12.50M
Short InterestN/A
🏛 Institutional Holdings
QoQ: ↓ 6.7% shares (2025Q4 vs prior)
19 institutional holders · 658.2K shares
#1 VANGUARD GROUP INC 304.2K shares
#2 DRW Securities, LLC 115.9K shares
#3 GEODE CAPITAL MANAGEMENT, LLC 56.3K shares
+ 16 more holders Sign up free to view →
📉 Short Interest
Short Interest316.1K
Days to Cover2.7
% of Float5.5%
FINRA data as of Mar 31, 2026
📁 Recent SEC Activity
xbrl XBRL WARRANT Dec 31, 2024
xbrl XBRL CONVERTIBLE Dec 31, 2020
Full SEC filing analysis available with free account
📰 Recent News
No recent news
Track VVOS Dilution Risk in Real-Time
Get instant alerts when SEC filings impact dilution risk. Free tier available.
Start Tracking VVOS — Free
Real-time SEC alerts DilutionScore™ tracking No credit card required